Pioneering company in non-genomic liquid biopsy cancer diagnostic
4D Lifetec has raised €1.9M across 1 funding round, most recently a Series B round in Jul 2022. Based in Zug, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-18 | Series B | €1.9M |
| — |
| View deal → |
